For the best experienceDownload the Mobile App
App Store Play Store
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
High insulin prices spur a federal lawsuit against three pharmacy benefit managers

Published on: 09/20/2024

This news was posted by Oregon Today News

Go To Business Place

Description

The FTC said the rebating practices of three companies — Caremark, Express Scripts and OptumRx — have led to artificially inflated list prices.

News Source : https://www.kgw.com/article/news/nation-world/high-insulin-prices-federal-lawsuit-against-pharmacy-benefit-managers/507-b3347b36-5e9c-4ade-810c-1e4e31b06431

Other Related News

09/20/2024

The 18-year-old charged in the fatal shooting made his first court appearance FridayTheyve...

09/20/2024

LaToya Hills fianc stated that Gates knew their family well and had a brother who once liv...

09/20/2024

Residential wells supporting hundreds of eastern Oregon households are unusable due to uns...

ShoutoutGive Shoutout
500/500